Outlook Therapeutics Inc

The current institutional shareholding score of Outlook Therapeutics Inc is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 8.33%, representing a quarter-over-quarter increase of 40.96%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.24% of shares outstanding, with 50.66% increase in holdings.